CELF2, a suppressor of glioma progression (Fig. 5b), was reported as an important regulator of many AS events across solid cancer samples [46] and exhibited a strong negative correlation with pST1-specific splicing events (Fig. 5a), indicating its key role in glioma suppression via the regulation of numerous splicing events. The gene discussed is CELF2; the disease is glioma.